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ABSTRACT
Human microbiome contains the genetic pool of bacteria and other microbes such as Achaea, fungi and viruses inhabiting 
the human body. It holds an immense potential to affect both physiological and pathological processes. The microbiome’s 
composition can be defined in detail by analyzing ribosomal 16S rRNA and metagenomic tests. Recent increases in cesar-
ean sections, the use of antibiotics during pregnancy, the increasing amount of prematurely born children and changes in 
infant nutrition have an impact on the microbiome forming process. A correlation between the bowel microbiome’s com-
position and the occurrence of certain diseases, especially inflammatory bowel diseases (IBD), asthma and type 1 diabetes 
has been demonstrated. The influence on the development of cognitive functions and behaviour has also been displayed. 
This correlation justifies attempts to restore the beneficial the composition of the microbiome through the use of probiotics, 
vaginal microflora transfer in case of cesarean section and encouraging breastfeeding. Development of multiple studies on 
the topic of the human microbiome and its impact on the human body is necessary in order to reach final conclusions. The 
aim of this article is to summarize recent findings regarding the development of the human microbiome from the first days 
of life and the influence of changes in its composition on human health.
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INTRODUCTION
The human body is temporarily or permanently inhab-
ited by abundant microbes, whose number varies from 
equal to triple the amount of human cells, depending on 
the source material. They are not distributed randomly; 
instead, they colonize certain areas, such as skin, upper 
respiratory tract, digestive tract and reproductive tract. The 
progress in the fields of microbiology, immunology and the 
expansion of new microbe identification methods have led 
to increased interest in the human microbiome. This term 
refers to the genetic pool of bacteria, Archaea, fungi, Protist 
and viruses inhabiting the human body. Regardless of the 
differences in the microbiome composition between spe-
cific individuals, distinct body areas contain similar microbe 
species. Microbiome’s influence on the functioning of the 
human body is an important and fascinating aspect of the 
research papers. Its effect on the immune, endocrine and 
nervous systems has been featured in multiple publica-
tions [1]. Numerous prenatal and postnatal factors, such as 
the delivery method, intrauterine environment, perinatal 
antibiotic therapy, the nature and order of introduced food, 
genetic and environmental factors cause changes in the 
microbiome. Our intent is to review the current knowledge 
on the microbiome development in subsequent stages of 
human life, with particular emphasis on the first three years; 
and its impact on the functioning of the body.
Microbiome identification
There are many methods for microbiome analysis:
 Ū Culturing of bacteria — the gold standard for microbial 
identification/not all species can be cultured
 Ū 16S rRNA sequence analysis by Sanger sequencing — it al-
lows identifying only one bacteria species in one test. It is 
impossible to sequence different 16s rRNA in one test [2].
 Ū qPCR — it allows to identify and quantify one bacteria 
species in one test.
 Ū MALDI-TOF MS (matrix-assisted laser desorption/ioniza-
tion time-of-flight mass spectrometry) — a new reliable 
tool for identification of bacteria and fungi cultivated on 
agar plates or in liquid media [3].
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Therefore the most efficient method is a high-through-
put sequencing based on NGS technique. This method al-
lows profiling whole microbial community by sequencing 
of 16s rRNA fragment gene. This analysis is possible because 
a small fragment of the 16s rRNA gene (ex. V3 and V4 re-
gions) sequence is unique for many community analyses, 
including those based on a phylogenetic  tree. This analytic 
process is divided into four main stages: DNA isolation, 
amplification of the 16s rRNA gene fragment, NGS analysis, 
clustering using Operational Taxonomic Unit method and 
annotation (bacterial’ type identification). This workflow 
gives us information about species and the amount of bac-
teria present in our sample. MALDI-TOF MS allows identifica-
tion of micro-organisms direct from positive blood cultures, 
subtyping, and drug susceptibility detection.
MICROBIOME’S IMPACT ON STAGES OF 
HUMAN’S DEVELOPMENT
Prenatal period
For many years, the intrauterine environment has been 
considered to be sterile during an uncomplicated preg-
nancy. Currently, however, this view is getting questioned by 
certain researchers [4]. Research on amniotic fluid, umbilical 
cord blood, fetal membranes, placenta and meconium from 
pregnancies delivered in the term, both through a vagi-
nal birth and the cesarean section has shown a presence 
of microbes in the samples [5, 6]. One hypothesis implies 
a vertical bacteria transfer from the maternal microbiota. 
It is supported by the results of a study performed on mice, 
which has shown the presence of genetically marked E. 
faecium in the amniotic fluid and meconium of mice whose 
mothers received food containing this species of bacteria. 
The marked bacteria were absent in mice from the control 
group [7]. Contact with microbes in the intrauterine envi-
ronment could hold significance in the development of 
the immune system. The discovery of a potential vertical 
bacteria transfer has raised the interest in the maternal 
intestinal flora during pregnancy. Probiotic supplementa-
tion during pregnancy modulates the development of the 
immune system according to one of the studies [8]. Maternal 
probiotic supplementation substantially modulated the im-
mune gene expression profile (TLR-related genes) both in 
the placenta and in the fetal gut. Final conclusions cannot 
be drawn until there is more research regarding this subject. 
The prenatal antibiotic exposure and its intensity could af-
fect the composition of gut microbiota in preterm infants [9]. 
Childbirth
The delivery type and gestational age bear an impact on 
the microbiome composition in early life [10]. The vaginal 
microflora changes during pregnancy, its diversity diminish-
es and Lactobacillus species (L. iners, L. crispatus, L. jensenii, 
L. johnsonii) emerges as dominant [11]. Newborns delivered 
by natural labour are primarily colonized by bacteria from 
maternal reproductive tract, belonging to the Lactobacillus, 
Bifidobacterium species and most likely intestinal Entero-
bacteriaceae species [12]. Contact with the mother’s skin 
after birth enables the transfer of Staphylococci. Newborns 
delivered by cesarean section do not have direct contact 
with the maternal microbiota, instead, they’re colonized 
by microflora characteristic for the skin and the hospital 
environment [13]. This is reflected in the intestinal micro-
biome composition of these newborns. Staphylococcus, 
Corynebacterium and Propionibacterium species become 
the dominant genera, with a considerably lower share of 
Bifidobacterium and Bacteroides species [14]. Differences 
in the intestinal microbiome of newborns delivered by ce-
sarean section can be visible up to seven years after birth. 
Children born prematurely or with low birth weight will 
most likely exhibit a different microbiome composition [15]. 
It may be caused by a higher percentage of delivery by cesar-
ean section in these cases, as well as more common perinatal 
antibiotic therapy. Newborns in these groups more often 
require prolonged hospitalization in a neonatal intensive 
care unit (NICU) and in many cases develop a characteris-
tic for NICU non physiological flora [16]. Dominguez-Bello 
et al. investigated the possibility of restoration the physi-
ological microflora of the newborn. One hour before the 
planned cesarean section, sterile gauze was placed in the 
mother’s vagina, in order to wipe the mouth, face and the 
rest of the body of the newborn after delivery. It has been 
shown that microbiome in the anal swab of children that 
have undergone the aforementioned procedure held more 
similarities to the microbiome of newborns delivered natu-
rally, than those from the control group [17]. This procedure, 
despite the potential benefits following a more physiologi-
cal composition of the microbiome, is currently not recom-
mended due to the need for closer examination of potential 
risks for the newborn ensuing from the procedure [18]. 
Concerns relate in particular to the exposure to pathogenic 
microorganisms, such as HSV, group B Streptococci, Chla-
mydia trachomatis, and Neisseria gonorrhoeae. 
Early years of life
In the first months of life, the infant receives all nutrients 
via breast milk or a suitable formula. Breast milk facilitates the 
colonization and maturation of newborn’s microbiota after 
birth. It contains bacteria [19, 20], the count and composition 
of which vary with the duration of the lactation, as well as 
the mother’s age and health. Furthermore, the microbiome 
composition of the breast milk may change depending on 
the mother’s caloric intake, her BMI, the delivery method 
and the sex of the child [21]. Bacteria present in breast milk 
belong primarily to Staphylococcus, Streptococcus, Serratia, 
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Pseudomonas, Corynebacterium genera [22] as well as Bifi-
dobacterium and Lactobacillus. The intestinal microbiome 
of infants fed naturally is dominated by Bifidobacterium 
and Bacteroides, which is most likely due to the presence 
of human milk oligosaccharides (HMO) in the milk, acting 
as prebiotics stimulating the growth of aforementioned 
bacteria. Formula-fed infants present a different intestinal 
microflora, dominated by Staphylococcus, anaerobic Strep-
tococcus and Clostridium species. The introduction of solid 
foods is associated with a gradual transformation of the 
microbiome into the one observed in adults, which lasts 
until the age of three years [23]. The introduction of solid 
foods leads to a rapid increase in the number of bacteria from 
Enterobacteriaceae and Enterococcus species, with simulta-
neous further colonization by Bacteroides, Clostridium and 
anaerobic Streptococcus species. The type of consumed food 
and also have a significant impact on the intestinal microbi-
ome [24]. Research on the development of the microbiome 
in the first three key years of life, especially on the intestinal 
microflora is crucial, due to its potential effect on individual 
development, along with the risk of certain diseases. 
Microbiome’s impact on health
Conclusions from numerous researches on the hu-
man microbiome show a correlation between the distur-
bances in the host’s microbiome and an increased risk of 
certain diseases [25]. The presented correlation applies 
primarily to gastrointestinal, dermatological, neurodegen-
erative, neuropsychiatric, neuroimmune diseases, obesity 
and type 1 diabetes.
Atopy
Allergic diseases can be described as an early manifesta-
tion of the immune system dysregulation. Microbes residing 
in the infant’s body have a significant role in shaping the 
immune system of the child. Exposure to environmental 
factors such as maternal infections, diet, bacterial coloniza-
tion, toxic compounds may directly or indirectly influence 
the development of the immune system, both in utero 
and postnatal life. Exposure to certain microorganisms in 
early childhood reduces the risk of certain diseases such 
as inflammatory bowel disease (IBD) or asthma. However, 
no correlation has been shown between the place of birth 
and the predisposition to inhalation allergy [26] A study on 
germ-free mice has proven that exposure to commensal 
microbes in the early years of development is a protec-
tive factor against the development of these diseases [27]. 
Caesarean delivery has been shown to be associated with 
a higher risk of developing asthma in children, as children 
delivered via cesarean section in a hospital displayed a sig-
nificantly higher percentage of C. difficile colonization. This 
correlation concerned children with a familial occurrence 
of atopy. Furthermore, a relation has been found for these 
children between cesarean delivery and a higher risk of food 
allergy and eczema. Another study has displayed a 40% oc-
currence reduction of atopic dermatitis in children of moth-
ers, who received probiotics during pregnancy, compared 
to the control group [28]. Moreover, children delivered by 
cesarean section display a significantly lower level of Th1 re-
sponse in the first two years of life, which is associated with 
an increased risk of developing allergic diseases. 
Gastrointestinal tract
Recently, the study of the influence of microbes residing 
in the human digestive tract on the development of inflam-
matory diseases in strongly emphasized. Study of 447 chil-
dren with Crohn’s disease has shown a smaller variety of 
microbiome, an increased number of Enterobacteriaceae, 
Pasteurellaceae, Fusobacteriaceae, Neisseriaceae, Veillonel-
laceae and Gemellaceae, as well as a decreased percent-
age of Bifidobacteriaceae, Erysipelotrichaceae, Clostridiales 
and Bacteroidales, compared to the control group [29]. 
Brown et al. have shown in their earlier cohort study on stool 
samples from Finnish children taxonomical differences in 
the intestinal microflora composition between the children 
affected by autoimmune diseases and healthy ones. Fur-
ther metagenomic analysis of the intestinal microbiome 
suggested a functional model of the development of au-
toimmunity in type 1 diabetes. The microbiome of healthy 
children turned out to be significantly more functionally 
diverse compared to the autoimmune microbiome [30]. 
Latest analyses suggest a possibility of preventing the devel-
opment of type 1 diabetes by modulating the intestinal mi-
crobiota. Experiments on rats treated with Freund adjuvant 
and Lactobacillus strains have shown a delay or a decrease 
in diabetes occurrence [31]. 
Neurodevelopment
The composition of the intestinal microbiome is con-
nected to the development of the neuronal connectivity 
system. Changes in its contents in the prenatal and postnatal 
period may have an influence on neurological development. 
It has been hypothesized that this phenomenon takes place 
through the microbiome-gut-brain axis, involving, among 
others, neurotrophic factors, susceptible to epigenetic regu-
lation [32, 33]. Extensive communication between the diges-
tive tract and the brain through the gut-brain axis is present 
since the very early stages of the organism’s development. 
The mechanism of the communication between the micro-
biota and the brain is not yet fully understood, however, 
it is postulated that they are affected by immunological, 
endocrine, metabolic and neuronal processes [34]. Mice 
deprived of the microbial exposition show underdevelop-
ment of both innate and adaptive immune system. Recently 
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scientists’ attention is drawn to the role of the microbiome in 
neuropsychiatry [35]. It has been noticed that the intestinal 
bacteria affect behaviour and cognitive processes. Currently, 
the amount of data indicating an impact of the intestinal 
microbiota on the brain and behaviour keeps increasing [36]. 
Since it has been proven that the intestinal microbiome may 
influence the central nervous system, it has been proposed 
to include the microbiome as a port of this axis, calling it the 
microbiota-gut-brain axis or the microbiome-gut-brain axis 
(MGB) . The intestinal microbiome is capable of affecting the 
host’s gene expression, which is crucial if genes responsible 
for the functioning of the central nervous system are taken 
into account, probably through modulation of the hypotha-
lamic-pituitary-adrenal axis, immune system, neurotrans-
mitter and growth factor pathways, possibly also the limbic 
system, especially the amygdala and hypothalamus.  Host 
microbiota is the main source of microbial antigens for the 
host, which are an important modulating factor in the de-
velopment of the immune system, through promoting the 
formation of lymphoid tissue in the intestines. Furthermore, 
the intestines form an anatomical barrier, separating the 
visceral systems from local bacteria. Gut dysbiosis is associ-
ated with an increase of the immune cells’ activity, cytokine 
production among others, which leads to an impairment 
of the intestinal barrier and subsequent chronic inflam-
mation. The presence of neuropsychiatric diseases is often 
connected to disorders of the gastrointestinal tract, which 
are associated with the intestinal dysbiosis. Stress in early 
childhood, such as separation from the mother in the neo-
natal period, is associated with an intestinal dysfunction [37]. 
A specific microbiome has also been observed in depres-
sion, comprising of an increased count of Bacteroidales and 
decrease of Lachnospiraceae, as well as an increase in the 
population of Alistipes and Enterobacteriaceae together 
with a decreased Faecalibacterium percentage [38]. Moreo-
ver, a protective effect of the last group on the development 
of neuropsychiatric diseases, including depression, has been 
noted. The presented data indicate a significant association 
between the intestinal microflora and the central nervous 
system through communication at the MGB axis level. This 
association may affect the pathophysiology of depression, 
developing since the prenatal period until adulthood, on the 
foundation of early stress factors [39]. Extensive communi-
cation between the digestive tract and the brain through 
the gut-brain axis is present since the very early stages of 
the organism’s development and could be a potent target 
for the treatment of neuropsychiatric disorders, including 
depression, due to its bi-directionality [40].
SUMMARY
Previous research on the subject of the human micro-
biome shows that the course of pregnancy, delivery type, as 
well as the type of feeding of babies, influence the develop-
ment of the human microbiome at an early stage of life. This 
correlation causes a higher incidence of certain diseases and 
disorders in those children who show abnormalities in the 
composition of their microbiome, mainly intestinal. Many 
studies still need to be confirmed or extended in order to 
be able to draw far-reaching conclusions.
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